Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Prilosec Applesauce Test Is New Hurdle For Generics; Andrx Sees No Delay

Executive Summary

Andrx does not expect its generic version of Prilosec to be delayed by a requirement to match AstraZeneca's new labeling regarding use of omeprazole sprinkled in applesauce

You may also be interested in...



Fasted/Fed BE Studies Should Eliminate Need For Special Food Tests – GPhA

If a generic demonstrates bioequivalence in both fed and fasted studies, specific food tests are unnecessary, Mylan Executive Director- Pharmacokinetics & Drug Metabolism Russell Rackley, PhD, said

Fasted/Fed BE Studies Should Eliminate Need For Special Food Tests – GPhA

If a generic demonstrates bioequivalence in both fed and fasted studies, specific food tests are unnecessary, Mylan Executive Director- Pharmacokinetics & Drug Metabolism Russell Rackley, PhD, said

AstraZeneca Prilosec Patent Litigation Decision By Mid-Year, Andrx Says

Andrx expects a decision regarding AstraZeneca's Prilosec (omeprazole) patent litigation by mid-year

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS038838

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel